María Larrousse

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients

Montserrat Laguno, Javier Murillas, José Luís Blanco et al. · AIDS · 2004 · 388 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy

Anna Suy, Estebán Martínez, Oriol Coll et al. · AIDS · 2005 · 198 citations

Public Health, Maternal Health, Obstetrics +17

Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study

Estebán Martínez, María Larrousse, Josep M. Llibre et al. · AIDS · 2010 · 192 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Incidence and causes of death in HIV‐infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area

Estebán Martínez, Ana Milinkovic, E Buira et al. · HIV Medicine · 2007 · 121 citations · Full text

Public Health, Health Sciences, Infectious Diseases +11

Randomized trial comparing pegylated interferon α‐2b versus pegylated interferon α‐2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients†

Montserrat Laguno, Javier Murillas, Sergio Veloso et al. · Hepatology · 2008 · 111 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17